nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolvaptan—ABCB1—Ezetimibe—atherosclerosis	0.102	0.152	CbGbCtD
Tolvaptan—ABCB1—Simvastatin—atherosclerosis	0.0951	0.141	CbGbCtD
Tolvaptan—ABCB1—Lovastatin—atherosclerosis	0.0931	0.138	CbGbCtD
Tolvaptan—ABCB1—Pravastatin—atherosclerosis	0.0931	0.138	CbGbCtD
Tolvaptan—CYP3A4—Rosuvastatin—atherosclerosis	0.0613	0.0909	CbGbCtD
Tolvaptan—CYP3A4—Ezetimibe—atherosclerosis	0.0613	0.0909	CbGbCtD
Tolvaptan—CYP3A4—Simvastatin—atherosclerosis	0.057	0.0845	CbGbCtD
Tolvaptan—CYP3A4—Lovastatin—atherosclerosis	0.0558	0.0827	CbGbCtD
Tolvaptan—CYP3A4—Pravastatin—atherosclerosis	0.0558	0.0827	CbGbCtD
Tolvaptan—Rhabdomyolysis—Rosuvastatin—atherosclerosis	0.00423	0.0286	CcSEcCtD
Tolvaptan—Rhabdomyolysis—Lovastatin—atherosclerosis	0.00358	0.0243	CcSEcCtD
Tolvaptan—Rhabdomyolysis—Ezetimibe—atherosclerosis	0.00352	0.0238	CcSEcCtD
Tolvaptan—Rhabdomyolysis—Simvastatin—atherosclerosis	0.00335	0.0227	CcSEcCtD
Tolvaptan—Rhabdomyolysis—Niacin—atherosclerosis	0.00308	0.0209	CcSEcCtD
Tolvaptan—Rhabdomyolysis—Pravastatin—atherosclerosis	0.00303	0.0205	CcSEcCtD
Tolvaptan—Hyperuricaemia—Niacin—atherosclerosis	0.00294	0.0199	CcSEcCtD
Tolvaptan—Blood uric acid increased—Niacin—atherosclerosis	0.00277	0.0188	CcSEcCtD
Tolvaptan—Urine output increased—Niacin—atherosclerosis	0.00246	0.0167	CcSEcCtD
Tolvaptan—Breast disorder—Rosuvastatin—atherosclerosis	0.00246	0.0166	CcSEcCtD
Tolvaptan—Polyuria—Niacin—atherosclerosis	0.00225	0.0153	CcSEcCtD
Tolvaptan—Breast disorder—Ezetimibe—atherosclerosis	0.00204	0.0138	CcSEcCtD
Tolvaptan—Aspartate aminotransferase increased—Ezetimibe—atherosclerosis	0.00203	0.0138	CcSEcCtD
Tolvaptan—Alanine aminotransferase increased—Ezetimibe—atherosclerosis	0.00199	0.0135	CcSEcCtD
Tolvaptan—Gastrointestinal haemorrhage—Niacin—atherosclerosis	0.00198	0.0134	CcSEcCtD
Tolvaptan—Orthostatic hypotension—Niacin—atherosclerosis	0.00181	0.0122	CcSEcCtD
Tolvaptan—Alanine aminotransferase increased—Pravastatin—atherosclerosis	0.00172	0.0116	CcSEcCtD
Tolvaptan—Connective tissue disorder—Ezetimibe—atherosclerosis	0.00154	0.0104	CcSEcCtD
Tolvaptan—Angiopathy—Ezetimibe—atherosclerosis	0.00142	0.0096	CcSEcCtD
Tolvaptan—Immune system disorder—Ezetimibe—atherosclerosis	0.00141	0.00956	CcSEcCtD
Tolvaptan—Mediastinal disorder—Ezetimibe—atherosclerosis	0.00141	0.00954	CcSEcCtD
Tolvaptan—Malnutrition—Ezetimibe—atherosclerosis	0.00136	0.00921	CcSEcCtD
Tolvaptan—Dysgeusia—Lovastatin—atherosclerosis	0.00136	0.0092	CcSEcCtD
Tolvaptan—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00131	0.00887	CcSEcCtD
Tolvaptan—Ill-defined disorder—Lovastatin—atherosclerosis	0.00129	0.00871	CcSEcCtD
Tolvaptan—Dysgeusia—Simvastatin—atherosclerosis	0.00127	0.0086	CcSEcCtD
Tolvaptan—Ill-defined disorder—Ezetimibe—atherosclerosis	0.00126	0.00855	CcSEcCtD
Tolvaptan—Malaise—Lovastatin—atherosclerosis	0.00125	0.00847	CcSEcCtD
Tolvaptan—Cardiac disorder—Pravastatin—atherosclerosis	0.00125	0.00847	CcSEcCtD
Tolvaptan—Angiopathy—Niacin—atherosclerosis	0.00124	0.00841	CcSEcCtD
Tolvaptan—Malaise—Ezetimibe—atherosclerosis	0.00123	0.00831	CcSEcCtD
Tolvaptan—Ill-defined disorder—Simvastatin—atherosclerosis	0.0012	0.00815	CcSEcCtD
Tolvaptan—Malnutrition—Niacin—atherosclerosis	0.00119	0.00807	CcSEcCtD
Tolvaptan—Malaise—Simvastatin—atherosclerosis	0.00117	0.00792	CcSEcCtD
Tolvaptan—Discomfort—Lovastatin—atherosclerosis	0.00117	0.0079	CcSEcCtD
Tolvaptan—Dry mouth—Lovastatin—atherosclerosis	0.00115	0.00782	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00115	0.00779	CcSEcCtD
Tolvaptan—Dysgeusia—Pravastatin—atherosclerosis	0.00115	0.00778	CcSEcCtD
Tolvaptan—Discomfort—Ezetimibe—atherosclerosis	0.00114	0.00775	CcSEcCtD
Tolvaptan—Constipation—Rosuvastatin—atherosclerosis	0.00114	0.00773	CcSEcCtD
Tolvaptan—Dry mouth—Ezetimibe—atherosclerosis	0.00113	0.00767	CcSEcCtD
Tolvaptan—Anaphylactic shock—Lovastatin—atherosclerosis	0.00113	0.00766	CcSEcCtD
Tolvaptan—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00111	0.00752	CcSEcCtD
Tolvaptan—Feeling abnormal—Rosuvastatin—atherosclerosis	0.0011	0.00745	CcSEcCtD
Tolvaptan—Discomfort—Simvastatin—atherosclerosis	0.00109	0.00739	CcSEcCtD
Tolvaptan—Nervous system disorder—Ezetimibe—atherosclerosis	0.00109	0.00737	CcSEcCtD
Tolvaptan—Ill-defined disorder—Pravastatin—atherosclerosis	0.00109	0.00737	CcSEcCtD
Tolvaptan—Anorexia—Lovastatin—atherosclerosis	0.00108	0.00731	CcSEcCtD
Tolvaptan—Skin disorder—Ezetimibe—atherosclerosis	0.00108	0.0073	CcSEcCtD
Tolvaptan—Syncope—Niacin—atherosclerosis	0.00107	0.00723	CcSEcCtD
Tolvaptan—Anaphylactic shock—Simvastatin—atherosclerosis	0.00106	0.00717	CcSEcCtD
Tolvaptan—Malaise—Pravastatin—atherosclerosis	0.00106	0.00716	CcSEcCtD
Tolvaptan—Loss of consciousness—Niacin—atherosclerosis	0.00105	0.00709	CcSEcCtD
Tolvaptan—Anorexia—Simvastatin—atherosclerosis	0.00101	0.00683	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00101	0.00682	CcSEcCtD
Tolvaptan—Dry mouth—Niacin—atherosclerosis	0.000992	0.00672	CcSEcCtD
Tolvaptan—Discomfort—Pravastatin—atherosclerosis	0.000986	0.00668	CcSEcCtD
Tolvaptan—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000984	0.00666	CcSEcCtD
Tolvaptan—Decreased appetite—Lovastatin—atherosclerosis	0.000984	0.00666	CcSEcCtD
Tolvaptan—Anaphylactic shock—Niacin—atherosclerosis	0.000972	0.00658	CcSEcCtD
Tolvaptan—Constipation—Lovastatin—atherosclerosis	0.000968	0.00655	CcSEcCtD
Tolvaptan—Decreased appetite—Ezetimibe—atherosclerosis	0.000965	0.00653	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000958	0.00649	CcSEcCtD
Tolvaptan—Asthenia—Rosuvastatin—atherosclerosis	0.000958	0.00649	CcSEcCtD
Tolvaptan—Anaphylactic shock—Pravastatin—atherosclerosis	0.000957	0.00648	CcSEcCtD
Tolvaptan—Shock—Niacin—atherosclerosis	0.000956	0.00648	CcSEcCtD
Tolvaptan—Constipation—Ezetimibe—atherosclerosis	0.000949	0.00643	CcSEcCtD
Tolvaptan—Pruritus—Rosuvastatin—atherosclerosis	0.000945	0.0064	CcSEcCtD
Tolvaptan—Skin disorder—Niacin—atherosclerosis	0.000944	0.00639	CcSEcCtD
Tolvaptan—Feeling abnormal—Lovastatin—atherosclerosis	0.000933	0.00632	CcSEcCtD
Tolvaptan—Anorexia—Niacin—atherosclerosis	0.000926	0.00627	CcSEcCtD
Tolvaptan—Decreased appetite—Simvastatin—atherosclerosis	0.00092	0.00623	CcSEcCtD
Tolvaptan—Feeling abnormal—Ezetimibe—atherosclerosis	0.000915	0.00619	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000914	0.00619	CcSEcCtD
Tolvaptan—Diarrhoea—Rosuvastatin—atherosclerosis	0.000914	0.00619	CcSEcCtD
Tolvaptan—Anorexia—Pravastatin—atherosclerosis	0.000912	0.00618	CcSEcCtD
Tolvaptan—Constipation—Simvastatin—atherosclerosis	0.000905	0.00613	CcSEcCtD
Tolvaptan—Body temperature increased—Lovastatin—atherosclerosis	0.000895	0.00606	CcSEcCtD
Tolvaptan—Dizziness—Rosuvastatin—atherosclerosis	0.000883	0.00598	CcSEcCtD
Tolvaptan—Body temperature increased—Ezetimibe—atherosclerosis	0.000877	0.00594	CcSEcCtD
Tolvaptan—Feeling abnormal—Simvastatin—atherosclerosis	0.000872	0.00591	CcSEcCtD
Tolvaptan—Decreased appetite—Niacin—atherosclerosis	0.000845	0.00572	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Niacin—atherosclerosis	0.000839	0.00568	CcSEcCtD
Tolvaptan—Body temperature increased—Simvastatin—atherosclerosis	0.000837	0.00567	CcSEcCtD
Tolvaptan—Headache—Rosuvastatin—atherosclerosis	0.000837	0.00567	CcSEcCtD
Tolvaptan—Hypersensitivity—Lovastatin—atherosclerosis	0.000834	0.00565	CcSEcCtD
Tolvaptan—Decreased appetite—Pravastatin—atherosclerosis	0.000832	0.00563	CcSEcCtD
Tolvaptan—Constipation—Pravastatin—atherosclerosis	0.000818	0.00554	CcSEcCtD
Tolvaptan—Hypersensitivity—Ezetimibe—atherosclerosis	0.000818	0.00554	CcSEcCtD
Tolvaptan—Asthenia—Lovastatin—atherosclerosis	0.000812	0.0055	CcSEcCtD
Tolvaptan—Pruritus—Lovastatin—atherosclerosis	0.000801	0.00542	CcSEcCtD
Tolvaptan—Asthenia—Ezetimibe—atherosclerosis	0.000796	0.00539	CcSEcCtD
Tolvaptan—Nausea—Rosuvastatin—atherosclerosis	0.000793	0.00537	CcSEcCtD
Tolvaptan—Feeling abnormal—Pravastatin—atherosclerosis	0.000789	0.00534	CcSEcCtD
Tolvaptan—Pruritus—Ezetimibe—atherosclerosis	0.000785	0.00532	CcSEcCtD
Tolvaptan—Hypersensitivity—Simvastatin—atherosclerosis	0.00078	0.00528	CcSEcCtD
Tolvaptan—Diarrhoea—Lovastatin—atherosclerosis	0.000774	0.00524	CcSEcCtD
Tolvaptan—Body temperature increased—Niacin—atherosclerosis	0.000768	0.0052	CcSEcCtD
Tolvaptan—Asthenia—Simvastatin—atherosclerosis	0.000759	0.00514	CcSEcCtD
Tolvaptan—Diarrhoea—Ezetimibe—atherosclerosis	0.000759	0.00514	CcSEcCtD
Tolvaptan—Body temperature increased—Pravastatin—atherosclerosis	0.000757	0.00512	CcSEcCtD
Tolvaptan—Pruritus—Simvastatin—atherosclerosis	0.000749	0.00507	CcSEcCtD
Tolvaptan—Dizziness—Lovastatin—atherosclerosis	0.000748	0.00507	CcSEcCtD
Tolvaptan—Dizziness—Ezetimibe—atherosclerosis	0.000734	0.00497	CcSEcCtD
Tolvaptan—Diarrhoea—Simvastatin—atherosclerosis	0.000724	0.0049	CcSEcCtD
Tolvaptan—Hypersensitivity—Niacin—atherosclerosis	0.000716	0.00485	CcSEcCtD
Tolvaptan—Headache—Lovastatin—atherosclerosis	0.000709	0.0048	CcSEcCtD
Tolvaptan—Hypersensitivity—Pravastatin—atherosclerosis	0.000705	0.00477	CcSEcCtD
Tolvaptan—Dizziness—Simvastatin—atherosclerosis	0.0007	0.00474	CcSEcCtD
Tolvaptan—Asthenia—Niacin—atherosclerosis	0.000697	0.00472	CcSEcCtD
Tolvaptan—Headache—Ezetimibe—atherosclerosis	0.000695	0.00471	CcSEcCtD
Tolvaptan—Pruritus—Niacin—atherosclerosis	0.000688	0.00466	CcSEcCtD
Tolvaptan—Asthenia—Pravastatin—atherosclerosis	0.000687	0.00465	CcSEcCtD
Tolvaptan—Pruritus—Pravastatin—atherosclerosis	0.000677	0.00459	CcSEcCtD
Tolvaptan—Nausea—Lovastatin—atherosclerosis	0.000672	0.00455	CcSEcCtD
Tolvaptan—Diarrhoea—Niacin—atherosclerosis	0.000665	0.0045	CcSEcCtD
Tolvaptan—Headache—Simvastatin—atherosclerosis	0.000663	0.00449	CcSEcCtD
Tolvaptan—Nausea—Ezetimibe—atherosclerosis	0.000659	0.00446	CcSEcCtD
Tolvaptan—Diarrhoea—Pravastatin—atherosclerosis	0.000655	0.00443	CcSEcCtD
Tolvaptan—Dizziness—Niacin—atherosclerosis	0.000643	0.00435	CcSEcCtD
Tolvaptan—Dizziness—Pravastatin—atherosclerosis	0.000633	0.00429	CcSEcCtD
Tolvaptan—Nausea—Simvastatin—atherosclerosis	0.000629	0.00426	CcSEcCtD
Tolvaptan—Headache—Niacin—atherosclerosis	0.000609	0.00412	CcSEcCtD
Tolvaptan—Headache—Pravastatin—atherosclerosis	0.0006	0.00406	CcSEcCtD
Tolvaptan—Nausea—Niacin—atherosclerosis	0.000577	0.00391	CcSEcCtD
Tolvaptan—Nausea—Pravastatin—atherosclerosis	0.000568	0.00385	CcSEcCtD
Tolvaptan—AVPR1A—Signaling Pathways—VWF—atherosclerosis	0.000143	0.000807	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—PRKCG—atherosclerosis	0.000143	0.000805	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—APOC3—atherosclerosis	0.000143	0.000802	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—VWF—atherosclerosis	0.000142	0.000801	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—LDLR—atherosclerosis	0.000142	0.000797	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—APOC3—atherosclerosis	0.000141	0.000796	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—LDLR—atherosclerosis	0.000141	0.000791	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—atherosclerosis	0.00014	0.00079	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—AGT—atherosclerosis	0.00014	0.000785	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—AGT—atherosclerosis	0.000139	0.00078	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CCL3—atherosclerosis	0.000138	0.000778	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CCL3—atherosclerosis	0.000137	0.000773	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NCF1—atherosclerosis	0.000132	0.000746	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NCF1—atherosclerosis	0.000132	0.00074	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—IFNG—atherosclerosis	0.000129	0.000727	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—F2—atherosclerosis	0.000129	0.000726	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—F2—atherosclerosis	0.000128	0.00072	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—AGT—atherosclerosis	0.000127	0.000713	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—AGT—atherosclerosis	0.000126	0.000708	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CCR2—atherosclerosis	0.000125	0.000704	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—EDNRA—atherosclerosis	0.000125	0.000704	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CYBA—atherosclerosis	0.000125	0.000701	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—EDNRA—atherosclerosis	0.000124	0.000699	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CCR2—atherosclerosis	0.000124	0.000699	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CYBA—atherosclerosis	0.000124	0.000696	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000123	0.000694	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000123	0.000689	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PLAT—atherosclerosis	0.000122	0.000686	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—GHRL—atherosclerosis	0.000122	0.000686	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PARP1—atherosclerosis	0.000122	0.000686	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PARP1—atherosclerosis	0.000121	0.000681	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PLAT—atherosclerosis	0.000121	0.000681	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—GHRL—atherosclerosis	0.000121	0.000681	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—CXCL8—atherosclerosis	0.00012	0.000676	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—F2—atherosclerosis	0.000117	0.000659	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—F2—atherosclerosis	0.000116	0.000654	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—IL1B—atherosclerosis	0.000115	0.000648	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—ABCG1—atherosclerosis	0.000115	0.000647	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—atherosclerosis	0.000113	0.000636	CbGpPWpGaD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—atherosclerosis	0.000113	0.000634	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—PIK3CG—atherosclerosis	0.000112	0.000631	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—PIK3CG—atherosclerosis	0.000111	0.000626	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—KNG1—atherosclerosis	0.000107	0.000602	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—AGTR1—atherosclerosis	0.000106	0.000599	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—KNG1—atherosclerosis	0.000106	0.000598	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—AGTR1—atherosclerosis	0.000106	0.000594	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—CCL2—atherosclerosis	0.000104	0.000587	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	0.000104	0.000587	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PLG—atherosclerosis	0.000104	0.000583	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—CCL2—atherosclerosis	0.000104	0.000583	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PLG—atherosclerosis	0.000103	0.000579	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—atherosclerosis	0.000101	0.000567	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—SOCS3—atherosclerosis	9.82e-05	0.000552	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—VEGFA—atherosclerosis	9.76e-05	0.000549	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—SOCS3—atherosclerosis	9.75e-05	0.000548	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MMP3—atherosclerosis	9.48e-05	0.000534	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IGF2—atherosclerosis	9.44e-05	0.000531	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MMP3—atherosclerosis	9.41e-05	0.00053	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—TRPV1—atherosclerosis	9.38e-05	0.000528	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IGF2—atherosclerosis	9.37e-05	0.000527	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—APOB—atherosclerosis	9.16e-05	0.000516	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—APOB—atherosclerosis	9.1e-05	0.000512	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—CXCL8—atherosclerosis	9.09e-05	0.000511	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—ABCG5—atherosclerosis	9.02e-05	0.000508	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—CXCL8—atherosclerosis	9.02e-05	0.000508	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—EDN1—atherosclerosis	9.02e-05	0.000507	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—TGFB1—atherosclerosis	8.95e-05	0.000504	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—EDN1—atherosclerosis	8.95e-05	0.000504	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CCL5—atherosclerosis	8.95e-05	0.000504	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CCL5—atherosclerosis	8.88e-05	0.0005	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—LPL—atherosclerosis	8.75e-05	0.000492	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—LPL—atherosclerosis	8.69e-05	0.000489	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—atherosclerosis	8.52e-05	0.000479	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PRKCG—atherosclerosis	8.51e-05	0.000479	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PRKCG—atherosclerosis	8.45e-05	0.000475	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—TNF—atherosclerosis	8.36e-05	0.000471	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—LDLRAP1—atherosclerosis	8.36e-05	0.00047	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—SPP1—atherosclerosis	8.29e-05	0.000466	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—CXCL8—atherosclerosis	8.25e-05	0.000464	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—SPP1—atherosclerosis	8.23e-05	0.000463	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—CXCL8—atherosclerosis	8.19e-05	0.000461	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PLTP—atherosclerosis	7.86e-05	0.000442	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PDGFB—atherosclerosis	7.67e-05	0.000432	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PDGFB—atherosclerosis	7.61e-05	0.000428	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—AGT—atherosclerosis	7.49e-05	0.000421	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—AGT—atherosclerosis	7.43e-05	0.000418	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	7.37e-05	0.000415	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—LEP—atherosclerosis	7.33e-05	0.000413	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—APOE—atherosclerosis	7.33e-05	0.000413	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—APOE—atherosclerosis	7.28e-05	0.00041	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—LEP—atherosclerosis	7.28e-05	0.00041	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CAV1—atherosclerosis	7.27e-05	0.000409	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	7.26e-05	0.000409	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—APOA1—atherosclerosis	7.25e-05	0.000408	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CAV1—atherosclerosis	7.21e-05	0.000406	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—APOA1—atherosclerosis	7.2e-05	0.000405	CbGpPWpGaD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—AKT1—atherosclerosis	7.19e-05	0.000404	CbGpPWpGaD
Tolvaptan—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	7.16e-05	0.000403	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—ESR1—atherosclerosis	7e-05	0.000394	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—ESR1—atherosclerosis	6.95e-05	0.000391	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—F2—atherosclerosis	6.92e-05	0.000389	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—F2—atherosclerosis	6.87e-05	0.000386	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ABCG8—atherosclerosis	6.81e-05	0.000383	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—LTA4H—atherosclerosis	6.81e-05	0.000383	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—CETP—atherosclerosis	6.68e-05	0.000376	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PIK3CG—atherosclerosis	6.62e-05	0.000372	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PIK3CG—atherosclerosis	6.57e-05	0.00037	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—MAPK3—atherosclerosis	6.34e-05	0.000357	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—MAPK3—atherosclerosis	6.29e-05	0.000354	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—INS—atherosclerosis	6.27e-05	0.000353	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—INS—atherosclerosis	6.22e-05	0.00035	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CCL2—atherosclerosis	6.17e-05	0.000347	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CCL2—atherosclerosis	6.12e-05	0.000344	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	6.11e-05	0.000344	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IGF1—atherosclerosis	6.06e-05	0.000341	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IGF1—atherosclerosis	6.02e-05	0.000339	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—PLAT—atherosclerosis	5.89e-05	0.000331	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—SERPINE1—atherosclerosis	5.76e-05	0.000324	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—SERPINE1—atherosclerosis	5.71e-05	0.000322	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NOS3—atherosclerosis	5.49e-05	0.000309	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NOS3—atherosclerosis	5.46e-05	0.000307	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ABCG1—atherosclerosis	5.39e-05	0.000303	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	5.3e-05	0.000299	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	5.21e-05	0.000293	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	5.15e-05	0.00029	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—FABP4—atherosclerosis	5.06e-05	0.000285	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—LCAT—atherosclerosis	5.06e-05	0.000285	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—PLG—atherosclerosis	5.01e-05	0.000282	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—APOA4—atherosclerosis	4.97e-05	0.00028	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CYP7A1—atherosclerosis	4.88e-05	0.000275	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CXCL8—atherosclerosis	4.87e-05	0.000274	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PLTP—atherosclerosis	4.84e-05	0.000272	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CXCL8—atherosclerosis	4.84e-05	0.000272	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	4.81e-05	0.000271	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—AKT1—atherosclerosis	4.71e-05	0.000265	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—AKT1—atherosclerosis	4.67e-05	0.000263	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—IL6—atherosclerosis	4.63e-05	0.000261	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	4.62e-05	0.00026	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—IL6—atherosclerosis	4.6e-05	0.000259	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	4.55e-05	0.000256	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CYP27A1—atherosclerosis	4.51e-05	0.000254	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—APOB—atherosclerosis	4.43e-05	0.000249	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	4.42e-05	0.000249	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MMP9—atherosclerosis	4.41e-05	0.000248	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MMP9—atherosclerosis	4.38e-05	0.000246	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NFKB1—atherosclerosis	4.36e-05	0.000245	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NFKB1—atherosclerosis	4.33e-05	0.000244	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MAPK8—atherosclerosis	4.29e-05	0.000241	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PLA2G2A—atherosclerosis	4.28e-05	0.000241	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—APOA2—atherosclerosis	4.28e-05	0.000241	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ALOX5AP—atherosclerosis	4.28e-05	0.000241	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ALOX15—atherosclerosis	4.28e-05	0.000241	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—AKT1—atherosclerosis	4.28e-05	0.000241	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MAPK8—atherosclerosis	4.26e-05	0.00024	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—AKT1—atherosclerosis	4.25e-05	0.000239	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ABCG5—atherosclerosis	4.23e-05	0.000238	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ABCG8—atherosclerosis	4.2e-05	0.000236	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—LTA4H—atherosclerosis	4.2e-05	0.000236	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	4.13e-05	0.000232	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—LPA—atherosclerosis	4.08e-05	0.00023	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—VEGFA—atherosclerosis	3.96e-05	0.000223	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—BGN—atherosclerosis	3.95e-05	0.000222	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—VEGFA—atherosclerosis	3.93e-05	0.000221	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—STAT3—atherosclerosis	3.92e-05	0.000221	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—APOA5—atherosclerosis	3.91e-05	0.00022	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—STAT3—atherosclerosis	3.89e-05	0.000219	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PLA2G1B—atherosclerosis	3.77e-05	0.000212	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MAPK3—atherosclerosis	3.74e-05	0.000211	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	3.73e-05	0.00021	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MAPK3—atherosclerosis	3.72e-05	0.000209	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ALOX5—atherosclerosis	3.64e-05	0.000205	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TGFB1—atherosclerosis	3.63e-05	0.000204	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TGFB1—atherosclerosis	3.61e-05	0.000203	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	3.5e-05	0.000197	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ABCG1—atherosclerosis	3.32e-05	0.000187	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—NAMPT—atherosclerosis	3.26e-05	0.000184	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—LIPC—atherosclerosis	3.24e-05	0.000182	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—APOC3—atherosclerosis	3.22e-05	0.000181	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—LDLR—atherosclerosis	3.2e-05	0.00018	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CETP—atherosclerosis	3.13e-05	0.000176	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—FABP4—atherosclerosis	3.12e-05	0.000176	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—LCAT—atherosclerosis	3.12e-05	0.000176	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	3.07e-05	0.000173	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—APOA4—atherosclerosis	3.06e-05	0.000172	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CYP7A1—atherosclerosis	3.01e-05	0.000169	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—SCARB1—atherosclerosis	3e-05	0.000169	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—HMGCR—atherosclerosis	2.83e-05	0.000159	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CYP27A1—atherosclerosis	2.78e-05	0.000157	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	2.77e-05	0.000156	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IL6—atherosclerosis	2.74e-05	0.000154	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IL6—atherosclerosis	2.72e-05	0.000153	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ALOX15—atherosclerosis	2.64e-05	0.000148	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	2.64e-05	0.000148	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—APOA2—atherosclerosis	2.64e-05	0.000148	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	2.64e-05	0.000148	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ABCG5—atherosclerosis	2.6e-05	0.000147	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—AKT1—atherosclerosis	2.53e-05	0.000142	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ABCA1—atherosclerosis	2.52e-05	0.000142	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—LPA—atherosclerosis	2.52e-05	0.000142	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—AKT1—atherosclerosis	2.51e-05	0.000141	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—BGN—atherosclerosis	2.44e-05	0.000137	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—APOA5—atherosclerosis	2.41e-05	0.000136	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	2.32e-05	0.000131	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ALOX5—atherosclerosis	2.24e-05	0.000126	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—HMOX1—atherosclerosis	2.16e-05	0.000122	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—APOB—atherosclerosis	2.07e-05	0.000117	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GSTM1—atherosclerosis	2.02e-05	0.000113	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—NAMPT—atherosclerosis	2.01e-05	0.000113	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—LIPC—atherosclerosis	2e-05	0.000112	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—APOC3—atherosclerosis	1.99e-05	0.000112	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—LPL—atherosclerosis	1.98e-05	0.000111	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—LDLR—atherosclerosis	1.97e-05	0.000111	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GPX1—atherosclerosis	1.93e-05	0.000109	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CETP—atherosclerosis	1.93e-05	0.000108	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CD36—atherosclerosis	1.88e-05	0.000106	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SCARB1—atherosclerosis	1.85e-05	0.000104	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—MTHFR—atherosclerosis	1.78e-05	0.0001	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PPARA—atherosclerosis	1.75e-05	9.84e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—HMGCR—atherosclerosis	1.74e-05	9.81e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—AGT—atherosclerosis	1.69e-05	9.53e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—APOE—atherosclerosis	1.66e-05	9.34e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CAV1—atherosclerosis	1.64e-05	9.25e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—APOA1—atherosclerosis	1.64e-05	9.23e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ABCA1—atherosclerosis	1.55e-05	8.74e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PIK3CG—atherosclerosis	1.5e-05	8.42e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PPARG—atherosclerosis	1.44e-05	8.13e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—INS—atherosclerosis	1.42e-05	7.97e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—HMOX1—atherosclerosis	1.33e-05	7.5e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ALB—atherosclerosis	1.3e-05	7.31e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—APOB—atherosclerosis	1.28e-05	7.19e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—NOS3—atherosclerosis	1.24e-05	6.99e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GSTM1—atherosclerosis	1.24e-05	6.99e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—LPL—atherosclerosis	1.22e-05	6.86e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GPX1—atherosclerosis	1.19e-05	6.69e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CD36—atherosclerosis	1.16e-05	6.52e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PTGS2—atherosclerosis	1.14e-05	6.4e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—MTHFR—atherosclerosis	1.1e-05	6.18e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PPARA—atherosclerosis	1.08e-05	6.06e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—AGT—atherosclerosis	1.04e-05	5.87e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—APOE—atherosclerosis	1.02e-05	5.75e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CAV1—atherosclerosis	1.01e-05	5.7e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—APOA1—atherosclerosis	1.01e-05	5.69e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PIK3CG—atherosclerosis	9.22e-06	5.19e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PPARG—atherosclerosis	8.9e-06	5.01e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—INS—atherosclerosis	8.73e-06	4.91e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ALB—atherosclerosis	8e-06	4.5e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—NOS3—atherosclerosis	7.66e-06	4.31e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PTGS2—atherosclerosis	7e-06	3.94e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—AKT1—atherosclerosis	5.71e-06	3.21e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—AKT1—atherosclerosis	3.52e-06	1.98e-05	CbGpPWpGaD
